node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
AFMID | DDC | ENSVVUP00000020814 | ENSVVUP00000013689 | Kynurenine formamidase; Catalyzes the hydrolysis of N-formyl-L-kynurenine to L- kynurenine, the second step in the kynurenine pathway of tryptophan degradation. Kynurenine may be further oxidized to nicotinic acid, NAD(H) and NADP(H). Required for elimination of toxic metabolites. | aromatic-L-amino-acid decarboxylase. | 0.926 |
AFMID | FH | ENSVVUP00000020814 | ENSVVUP00000036897 | Kynurenine formamidase; Catalyzes the hydrolysis of N-formyl-L-kynurenine to L- kynurenine, the second step in the kynurenine pathway of tryptophan degradation. Kynurenine may be further oxidized to nicotinic acid, NAD(H) and NADP(H). Required for elimination of toxic metabolites. | Fumarate hydratase, mitochondrial. | 0.813 |
AFMID | IDO1 | ENSVVUP00000020814 | ENSVVUP00000027816 | Kynurenine formamidase; Catalyzes the hydrolysis of N-formyl-L-kynurenine to L- kynurenine, the second step in the kynurenine pathway of tryptophan degradation. Kynurenine may be further oxidized to nicotinic acid, NAD(H) and NADP(H). Required for elimination of toxic metabolites. | Indoleamine 2,3-dioxygenase 1. | 0.950 |
AFMID | IDO2 | ENSVVUP00000020814 | ENSVVUP00000027820 | Kynurenine formamidase; Catalyzes the hydrolysis of N-formyl-L-kynurenine to L- kynurenine, the second step in the kynurenine pathway of tryptophan degradation. Kynurenine may be further oxidized to nicotinic acid, NAD(H) and NADP(H). Required for elimination of toxic metabolites. | Indoleamine 2,3-dioxygenase 2. | 0.974 |
AFMID | KMO | ENSVVUP00000020814 | ENSVVUP00000036904 | Kynurenine formamidase; Catalyzes the hydrolysis of N-formyl-L-kynurenine to L- kynurenine, the second step in the kynurenine pathway of tryptophan degradation. Kynurenine may be further oxidized to nicotinic acid, NAD(H) and NADP(H). Required for elimination of toxic metabolites. | Kynurenine 3-monooxygenase; Catalyzes the hydroxylation of L-kynurenine (L-Kyn) to form 3-hydroxy-L-kynurenine (L-3OHKyn). Required for synthesis of quinolinic acid, a neurotoxic NMDA receptor antagonist and potential endogenous inhibitor of NMDA receptor signaling in axonal targeting, synaptogenesis and apoptosis during brain development. Quinolinic acid may also affect NMDA receptor signaling in pancreatic beta cells, osteoblasts, myocardial cells, and the gastrointestinal tract. | 0.970 |
AFMID | KYAT1 | ENSVVUP00000020814 | ENSVVUP00000036313 | Kynurenine formamidase; Catalyzes the hydrolysis of N-formyl-L-kynurenine to L- kynurenine, the second step in the kynurenine pathway of tryptophan degradation. Kynurenine may be further oxidized to nicotinic acid, NAD(H) and NADP(H). Required for elimination of toxic metabolites. | Kynurenine--oxoglutarate transaminase 1 isoform X1. | 0.971 |
AFMID | KYAT3 | ENSVVUP00000020814 | ENSVVUP00000042527 | Kynurenine formamidase; Catalyzes the hydrolysis of N-formyl-L-kynurenine to L- kynurenine, the second step in the kynurenine pathway of tryptophan degradation. Kynurenine may be further oxidized to nicotinic acid, NAD(H) and NADP(H). Required for elimination of toxic metabolites. | Kynurenine--oxoglutarate transaminase 3. | 0.973 |
AFMID | KYNU | ENSVVUP00000020814 | ENSVVUP00000014631 | Kynurenine formamidase; Catalyzes the hydrolysis of N-formyl-L-kynurenine to L- kynurenine, the second step in the kynurenine pathway of tryptophan degradation. Kynurenine may be further oxidized to nicotinic acid, NAD(H) and NADP(H). Required for elimination of toxic metabolites. | Kynureninase; Catalyzes the cleavage of L-kynurenine (L-Kyn) and L-3- hydroxykynurenine (L-3OHKyn) into anthranilic acid (AA) and 3- hydroxyanthranilic acid (3-OHAA), respectively. Has a preference for the L-3-hydroxy form. Also has cysteine-conjugate-beta-lyase activity. Belongs to the kynureninase family. | 0.975 |
AFMID | PCK1 | ENSVVUP00000020814 | ENSVVUP00000023511 | Kynurenine formamidase; Catalyzes the hydrolysis of N-formyl-L-kynurenine to L- kynurenine, the second step in the kynurenine pathway of tryptophan degradation. Kynurenine may be further oxidized to nicotinic acid, NAD(H) and NADP(H). Required for elimination of toxic metabolites. | Phosphoenolpyruvate carboxykinase, cytosolic [GTP]. | 0.813 |
AFMID | TDO2 | ENSVVUP00000020814 | ENSVVUP00000034504 | Kynurenine formamidase; Catalyzes the hydrolysis of N-formyl-L-kynurenine to L- kynurenine, the second step in the kynurenine pathway of tryptophan degradation. Kynurenine may be further oxidized to nicotinic acid, NAD(H) and NADP(H). Required for elimination of toxic metabolites. | Tryptophan 2,3-dioxygenase; Heme-dependent dioxygenase that catalyzes the oxidative cleavage of the L-tryptophan (L-Trp) pyrrole ring and converts L- tryptophan to N-formyl-L-kynurenine. Catalyzes the oxidative cleavage of the indole moiety. | 0.974 |
DDC | AFMID | ENSVVUP00000013689 | ENSVVUP00000020814 | aromatic-L-amino-acid decarboxylase. | Kynurenine formamidase; Catalyzes the hydrolysis of N-formyl-L-kynurenine to L- kynurenine, the second step in the kynurenine pathway of tryptophan degradation. Kynurenine may be further oxidized to nicotinic acid, NAD(H) and NADP(H). Required for elimination of toxic metabolites. | 0.926 |
DDC | IDO1 | ENSVVUP00000013689 | ENSVVUP00000027816 | aromatic-L-amino-acid decarboxylase. | Indoleamine 2,3-dioxygenase 1. | 0.908 |
DDC | IDO2 | ENSVVUP00000013689 | ENSVVUP00000027820 | aromatic-L-amino-acid decarboxylase. | Indoleamine 2,3-dioxygenase 2. | 0.909 |
DDC | KMO | ENSVVUP00000013689 | ENSVVUP00000036904 | aromatic-L-amino-acid decarboxylase. | Kynurenine 3-monooxygenase; Catalyzes the hydroxylation of L-kynurenine (L-Kyn) to form 3-hydroxy-L-kynurenine (L-3OHKyn). Required for synthesis of quinolinic acid, a neurotoxic NMDA receptor antagonist and potential endogenous inhibitor of NMDA receptor signaling in axonal targeting, synaptogenesis and apoptosis during brain development. Quinolinic acid may also affect NMDA receptor signaling in pancreatic beta cells, osteoblasts, myocardial cells, and the gastrointestinal tract. | 0.452 |
DDC | TDO2 | ENSVVUP00000013689 | ENSVVUP00000034504 | aromatic-L-amino-acid decarboxylase. | Tryptophan 2,3-dioxygenase; Heme-dependent dioxygenase that catalyzes the oxidative cleavage of the L-tryptophan (L-Trp) pyrrole ring and converts L- tryptophan to N-formyl-L-kynurenine. Catalyzes the oxidative cleavage of the indole moiety. | 0.907 |
FH | AFMID | ENSVVUP00000036897 | ENSVVUP00000020814 | Fumarate hydratase, mitochondrial. | Kynurenine formamidase; Catalyzes the hydrolysis of N-formyl-L-kynurenine to L- kynurenine, the second step in the kynurenine pathway of tryptophan degradation. Kynurenine may be further oxidized to nicotinic acid, NAD(H) and NADP(H). Required for elimination of toxic metabolites. | 0.813 |
FH | KMO | ENSVVUP00000036897 | ENSVVUP00000036904 | Fumarate hydratase, mitochondrial. | Kynurenine 3-monooxygenase; Catalyzes the hydroxylation of L-kynurenine (L-Kyn) to form 3-hydroxy-L-kynurenine (L-3OHKyn). Required for synthesis of quinolinic acid, a neurotoxic NMDA receptor antagonist and potential endogenous inhibitor of NMDA receptor signaling in axonal targeting, synaptogenesis and apoptosis during brain development. Quinolinic acid may also affect NMDA receptor signaling in pancreatic beta cells, osteoblasts, myocardial cells, and the gastrointestinal tract. | 0.559 |
FH | KYAT1 | ENSVVUP00000036897 | ENSVVUP00000036313 | Fumarate hydratase, mitochondrial. | Kynurenine--oxoglutarate transaminase 1 isoform X1. | 0.585 |
FH | KYAT3 | ENSVVUP00000036897 | ENSVVUP00000042527 | Fumarate hydratase, mitochondrial. | Kynurenine--oxoglutarate transaminase 3. | 0.585 |
IDO1 | AFMID | ENSVVUP00000027816 | ENSVVUP00000020814 | Indoleamine 2,3-dioxygenase 1. | Kynurenine formamidase; Catalyzes the hydrolysis of N-formyl-L-kynurenine to L- kynurenine, the second step in the kynurenine pathway of tryptophan degradation. Kynurenine may be further oxidized to nicotinic acid, NAD(H) and NADP(H). Required for elimination of toxic metabolites. | 0.950 |